2025
Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults
Du Z, Pandey A, Moghadas S, Bai Y, Wang L, Matrajt L, Singer B, Galvani A. Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults. Nature Medicine 2025, 31: 647-652. PMID: 39789324, PMCID: PMC11835734, DOI: 10.1038/s41591-024-03431-7.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusSyncytial virusRSV diseaseImpact of vaccinationBurden of respiratory syncytial virusVaccination of pregnant womenRSV-related mortalityProtein-based vaccinesVaccination of older adultsRSV vaccinePregnant womenSeasonal influenzaVaccine uptake ratesInfant hospitalizationClinical trialsPrefusion FHospital costsInfantsHealth burdenAdult immunizationVaccineOlder adultsHospitalEnhanced uptakeHigh-income countries
2017
Effectiveness of UNAIDS targets and HIV vaccination across 127 countries
Medlock J, Pandey A, Parpia AS, Tang A, Skrip LA, Galvani AP. Effectiveness of UNAIDS targets and HIV vaccination across 127 countries. Proceedings Of The National Academy Of Sciences Of The United States Of America 2017, 114: 4017-4022. PMID: 28320938, PMCID: PMC5393239, DOI: 10.1073/pnas.1620788114.Peer-Reviewed Original ResearchConceptsHIV/AIDS 95Joint United Nations ProgrammeOngoing clinical trialsRate of diagnosisBenefits of preventionAntiretroviral therapyHIV vaccinationViral suppressionUNAIDS targetsHIV controlUnited Nations ProgrammeHIV vaccineIncident casesClinical trialsHIV pandemicEnormous morbidityEfficacy vaccineEconomic burdenNew infectionsVaccine developmentDiagnostic approachNations ProgrammeVaccinePreventionTreatment
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply